EXOZ (Exozymes) VP Finance Nawaz Fouad Receives 45,000-Share Award

What Happened

• Nawaz Fouad, Vice President — Finance of Exozymes, was granted a 45,000-share derivative award on 2026-09-14. The Form 4 reports an acquisition price of $0.00 (total $0 as reported) and classifies the grant as a derivative (an option per the footnote). The filing was made on 2026-09-17.

Key Details

• Transaction date and price: Grant on 2026-09-14, reported acquisition price $0.00.
• Vesting: The award vests over three years in 12 equal quarterly installments of 3,750 shares each, beginning 12/31/2026; final installment vests 09/30/2029.
• Expiration: The option (award) expires 09/14/2033.
• Shares owned after transaction: Not reported in this Form 4.
• Filing timing: Form 4 filed 2026-09-17 for a 2026-09-14 grant (check filing timeliness if that matters to you).
• Footnote summary: Vesting schedule and expiration described above; award is treated as an option in the filing footnote.

Context

• This was a compensation award/derivative grant, not an open-market purchase or sale — no cash changed hands in this filing. Because the award vests over time, it represents potential future equity rather than immediate stock ownership. Such grants are common for executive compensation and do not by themselves indicate an insider buying or selling the stock.